Vischer advised Anokion in this transaction, while Walder Wyss advised Pfizer.Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance,…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Federica Tiefenthaler
…
This content is for Standard 1 Year members only. LoginJoin Now